BlackRock’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $48.3M | Sell |
|
|||||
|
2025
Q1 | $37.9M | Sell |
|
|||||
|
2024
Q4 | $60.5M | Buy |
|
|||||
|
2024
Q3 | $83.1M | Buy |
|
|||||
|
2024
Q2 | $68.7M | Buy |
|
|||||
|
2024
Q1 | $81.3M | Buy |
|
|||||
|
2023
Q4 | $105M | Buy |
|
|||||
|
2023
Q3 | $70.1M | Sell |
|
|||||
|
2023
Q2 | $105M | Buy |
|
|||||
|
2023
Q1 | $131M | Sell |
|
|||||
|
2022
Q4 | $119M | Buy |
|
|||||
|
2022
Q3 | $151M | Buy |
|
|||||
|
2022
Q2 | $110M | Buy |
|
|||||
|
2022
Q1 | $179M | Sell |
|
|||||
|
2021
Q4 | $184M | Buy |
|
|||||
|
2021
Q3 | $169M | Buy |
|
|||||
|
2021
Q2 | $166M | Buy |
|
|||||
|
2021
Q1 | $131M | Buy |
|
|||||
|
2020
Q4 | $131M | Buy |
|
|||||
|
2020
Q3 | $88M | Buy |
|